000			02137 a2200181 4500
008			240906b |||||||| |||| 00| 0 eng d
020			_a978-1-03-283793-2
082			_a615.1068/Aus _b38695
100			_aAustin, Martin _939056
245			_aBusiness development for biotechnology and the pharmaceutical industry
260			_aNew York _bRoutledge _c2008
300			_axii, 186p. _bPaperback
505			_aForeword; The role of business development; Planning the portfolio; Identifying the needs; Profiling and searching for opportunities; Modelling and valuation; Structuring the value; Due diligence and negotiations; Sealing the deal - the contract; Making the transaction work; Glossary; Index.
520			_aBusiness Development in the biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deal value per year and much more than that in the value of mergers and acquisitions. Transactions range from licences to patented academic research, to product developments as licences, joint ventures and acquisition of intellectual property rights, and on to collaborations in development and marketing, locally or across the globe. Asset sales, mergers and corporate takeovers are also a part of the business development remit. The scope of the job can be immense, spanning the life-cycle of products from the earliest levels of research to the disposal of residual marketing rights, involving legal regulatory manufacturing, clinical development, sales and marketing and financial aspects. The knowledge and skills required of practitioners must be similarly broad, yet the availability of information for developing a career in business development is sparse. Martin Austin's highly practical guide spans the complete process and is based on his 30 years of experience in the industry and the well-established training programme that he has developed and delivers to pharmaceutical executives from across the world.
650			_aBiotechnologies industries, Pharmaceutical industry _939143
942			_2ddc _cBK
999			_c55014 _d55014